Jublia
Drug - Jublia® (efinazonazole solution) [Valeant Pharmaceuticals North America LLC]
November 2014
Therapeutic area - Onychomycosis
Approval criteria
- Patient has a diagnosis of onychomycosis of the toenails AND
- Patient has tried and failed a 48 week course of ciclopirox AND
- Patient has a contraindication or intolerance to oral itraconazole or terbinafine
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411